title: Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease.
abstract: Clinical biochemical markers of bone turnover are usually increased in Paget's disease. However, the analysis of "new" markers, such as serum bone alkaline phosphatase (BAP), carboxy-terminal propeptide of type I procollagen (PICP), tartrate-resistant acid phosphatase (TRAP), telopeptide carboxy-terminal propeptide of type I collagen (ICTP), and urinary pyridinoline (PYR) and deoxipyridinoline (D-PYR), may improve the diagnostic efficacy and the evaluation of Paget's disease compared with conventional markers, such as serum total alkaline phosphatase (TAP) and urinary hydroxyproline (HYP). To evaluate the diagnostic accuracy and the changes of biochemical markers of bone turnover according to Paget's disease activity, we measured the levels of all these markers in three groups of pagetic patients classified according to their serum TAP activity: G-I, patients with serum TAP lower than 250 U/l (upper limit) (n = 15); G-II, patients with serum TAP between 251 and 500 U/l (n = 18); and G-III, patients with serum TAP greater than 501 U/l (n = 26). Serum TAP and BAP showed the highest diagnostic accuracy among the markers of bone formation with a sensitivity of 78% and 84%, respectively, when the specificity was 100%. Urinary PYR was the most sensitive marker of bone resorption. Also, urinary PYR showed the highest proportion of increased values in pagetic patients (73%) compared with urinary HYP (64%), urinary D-PYR (60%), serum ICTP (41%), or serum TRAP (39%). In pagetic patients with normal serum TAP activity (G-I), serum BAP concentration was increased in 60% of patients, and urinary PYR was increased in 40% of patients.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Service of Clinical Biochemistry, Hospital Clínic, University of Barcelona, Spain.
authors.forename: L
authors.initials: L
authors.lastname: Alvarez
authors.forename: N
authors.initials: N
authors.lastname: Guañabens
authors.forename: P
authors.initials: P
authors.lastname: Peris
authors.forename: A
authors.initials: A
authors.lastname: Monegal
authors.forename: J L
authors.initials: JL
authors.lastname: Bedini
authors.forename: R
authors.initials: R
authors.lastname: Deulofeu
authors.forename: M J
authors.initials: MJ
authors.lastname: Martinez de Osaba
authors.forename: J
authors.initials: J
authors.lastname: Muñoz-Gomez
authors.forename: F
authors.initials: F
authors.lastname: Rivera-Fillat
authors.forename: A M
authors.initials: AM
authors.lastname: Ballesta
mesh_terms: D000135:Acid Phosphatase / Q000097:blood; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000469:Alkaline Phosphatase / Q000097:blood* / Q000652:urine; D000596:Amino Acids / Q000652:urine; D015415:Biomarkers / Q000097:blood* / Q000652:urine; D001846:Bone Development / Q000502:physiology; D001862:Bone Resorption / Q000097:blood / Q000175:diagnosis / Q000652:urine; D003094:Collagen / Q000097:blood; D024042:Collagen Type I; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D006909:Hydroxyproline / Q000652:urine; D008297:Male; D008875:Middle Aged; D010001:Osteitis Deformans / Q000097:blood / Q000175:diagnosis* / Q000652:urine; D010446:Peptide Fragments / Q000097:blood; D010455:Peptides / Q000097:blood; D011347:Procollagen / Q000097:blood
chemical_list: D000596:Amino Acids; D015415:Biomarkers; D024042:Collagen Type I; D010446:Peptide Fragments; D010455:Peptides; D011347:Procollagen; C052929:collagen type I trimeric cross-linked peptide; C042813:procollagen type I carboxy terminal peptide; C015484:pyridinoline; C036020:deoxypyridinoline; D003094:Collagen; D000469:Alkaline Phosphatase; D000135:Acid Phosphatase; D006909:Hydroxyproline